SCHEMBL204849

SCHEMBL204849

COC(=O)c1cc(F)cc2nc(-c3ccc(C)cc3)oc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 4/20 0.65
MAPT P10636 5/20 0.52
RAB9A P51151 5/20 0.52
KDM4E B2RXH2 4/20 0.52
ALDH1A1 P00352 4/20 0.52
HPGD P15428 4/20 0.52
HSD17B10 Q99714 4/20 0.52
NPC1 O15118 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
ESR1 P03372 2/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
ATM Q13315 1/20 0.52
PKM P14618 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CETP P11597 7/20 0.47
TP53 P04637 3/20 0.47
THRB P10828 1/20 0.47
CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL204759 0.87 ESR2 (0.59) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL205470 0.86 ESR2 (0.60) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL206041 0.85 ESR2 (0.58) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL205527 0.84 ESR2 (0.57) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL205888 0.84 ESR2 (0.57) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL207162 0.82 ESR2 (0.55) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL205602 0.81 CETP (0.61) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL2957208 0.78 CETP (0.60) ESR2MAPTRAB9AKDM4EALDH1A1
SCHEMBL207416 0.74 PARP1 (0.53) ESR2MAPTALDH1A1HPGDHSD17B10
SCHEMBL2950808 0.74 ESR2 (0.62) ESR2MAPTRAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088760-B2 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) BIOMARIN PHARMACEUTICAL INC. (US) 2012-01-03 US disclosed
EP-2247600-A2 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) Lead Therapeutics, Inc. (US) 2010-11-10 EP disclosed
WO-2009099736-A2 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-13 WO disclosed
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) PARP1, PARP2, PARP11 ESR2 1492/4885MAPT 1527/4885RAB9A 3649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.